Literature DB >> 16682952

MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.

M Peter1, C Rosty, J Couturier, F Radvanyi, H Teshima, X Sastre-Garau.   

Abstract

To determine whether integration of human papillomavirus (HPV) DNA sequences could lead to the deregulation of genes implied in oncogenesis, we analysed the HPV integration sites in a series of nine cell lines derived from invasive genital carcinomas. Using in situ hybridization, HPV16 or 18 sequences were found at chromosome band 8q24, the localization of MYC, in IC1, IC2, IC3, IC6 and CAC-1 cells and at other sites in IC4, IC5, IC7 and IC8 cells. We then localized viral sequences at the molecular level and searched for alterations of MYC structure and expression in these cells. MYC genomic status and viral integration sites were also analysed in primary tumors from which IC1, IC2, IC3 and IC6 cells were derived. In IC1, IC2 and CAC-1 cells, HPV DNA was located within 58 kb of MYC, downstream, upstream, or within MYC. In IC3 and IC6 cells, HPV DNA was located 400-500 kb upstream of MYC. Amplification studies showed that, in IC1, IC2 and IC3, viral and MYC sequences were co-amplified in an amplicon between less than 50 and 800 kb in size. MYC amplification was also observed in primary tumors, indicating that this genetic alteration, together with viral insertion at the MYC locus, had already taken place in vivo. MYC was not amplified in the other cell lines. MYC mRNA and protein overexpression was observed in the five cell lines in which the HPV DNA was inserted close to the MYC locus, but in none of the lines where the insertion had occurred at other sites. MYC activation, triggered by the insertion of HPV DNA sequences, can be an important genetic event in cervical oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682952     DOI: 10.1038/sj.onc.1209625

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Identification and characterization of the human NOL7 gene promoter.

Authors:  Tanmayi P Mankame; Guolin Zhou; Mark W Lingen
Journal:  Gene       Date:  2010-03-03       Impact factor: 3.688

2.  Characterization of HPV and host genome interactions in primary head and neck cancers.

Authors:  Michael Parfenov; Chandra Sekhar Pedamallu; Nils Gehlenborg; Samuel S Freeman; Ludmila Danilova; Christopher A Bristow; Semin Lee; Angela G Hadjipanayis; Elena V Ivanova; Matthew D Wilkerson; Alexei Protopopov; Lixing Yang; Sahil Seth; Xingzhi Song; Jiabin Tang; Xiaojia Ren; Jianhua Zhang; Angeliki Pantazi; Netty Santoso; Andrew W Xu; Harshad Mahadeshwar; David A Wheeler; Robert I Haddad; Joonil Jung; Akinyemi I Ojesina; Natalia Issaeva; Wendell G Yarbrough; D Neil Hayes; Jennifer R Grandis; Adel K El-Naggar; Matthew Meyerson; Peter J Park; Lynda Chin; J G Seidman; Peter S Hammerman; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  You Don't Muck with MYC.

Authors:  David Levens
Journal:  Genes Cancer       Date:  2010-06-01

5.  Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.

Authors:  Jureeporn Chuerduangphui; Chamsai Pientong; Natcha Patarapadungkit; Apinya Chotiyano; Patravoot Vatanasapt; Bunkerd Kongyingyoes; Supannee Promthet; Piyawut Swangphon; Sureewan Bumrungthai; Charinya Pimson; Tipaya Ekalaksananan
Journal:  Med Oncol       Date:  2017-07-24       Impact factor: 3.064

Review 6.  [Value of targeted therapy for penile cancer].

Authors:  A Heidenreich; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

7.  Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.

Authors:  Celine J Guigon; Li Zhao; Changxue Lu; Mark C Willingham; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

8.  Genomic instability of the host cell induced by the human papillomavirus replication machinery.

Authors:  Meelis Kadaja; Alina Sumerina; Tatjana Verst; Mari Ojarand; Ene Ustav; Mart Ustav
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

Review 9.  Human papilloma virus (HPV) and host cellular interactions.

Authors:  Ioannis N Mammas; George Sourvinos; Athena Giannoudis; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

10.  Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens.

Authors:  Irina Sokolova; Alicia Algeciras-Schimnich; Minghao Song; Svetlana Sitailo; Frank Policht; Benjamin R Kipp; Jesse S Voss; Kevin C Halling; Adam Ruth; Walter King; Dawn Underwood; Jennifer Brainard; Larry Morrison
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.